
Utah Medical Products, Inc.
UTMDNASDAQHealthcareMedical - Instruments & Supplies
Previous close
$71.55
+$0.13 · +0.18%
Pre-market
$70.05
−$1.50 · -2.10%
Aug 24, 8:05 AM ET
UTMD company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Hold
Wait — insufficient conviction to act
Valuation
81
Deep Value
Momentum
51
Neutral
Sentiment
53
Mixed
Risk resilience
60
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteUtah Medical Products, Inc. (UTMD) is a healthcare technology company focused on the creation, production, and supply of medical devices for the healthcare sector. UTMD offers a comprehensive portfolio of medical devices primarily serving labor and delivery departments and neonatal intensive care units. Key offerings include fetal monitoring accessories, vacuum-assisted delivery systems, and other specialized tools for childbirth. For newborns, they provide respiratory hoods (DISPOSA-HOOD), umbilical vessel catheters (GESCO), silicone oral protection devices (PALA-NATE), and lumbar sampling kits (MYELO-NATE). Beyond maternity care, the company supplies blood pressure monitoring systems (DELTRAN PLUS), disposable peritoneal dialysis sets (DIALY-NATE), urinary drainage systems (URI-CATH), and feeding devices (NUTRI-CATH/NUTRI-LOK). They also manufacture HEMO-NATE disposable filters, various catheterization procedure trays, and DELTRAN disposable pressure transducers along with related accessories and molded parts. A substantial portion of UTMD's offerings targets women's health and gynecological interventions. This includes advanced electrosurgical solutions like the LETZ system for cervical lesion excision, paired with FINESSE+ generators and various specialized electrodes (loop, ball, needle), and FILTRESSE evacuators. They also provide laparoscopic instruments (Femcare line), including trocars and cannulae, alongside EPITOME and OptiMicro electrosurgical devices. Complementing these are products for surgical contraception (Filshie Clip), endoscopic irrigation (PATHFINDER PLUS), suprapubic catheterization, and urinary incontinence management (LIBERTY systems). Specialized tools for uterine assessment and sampling, such as the ENDOCURETTE and TVUS/HSG-Cath, as well as the LUMIN uterine manipulator for laparoscopic procedures, complete this extensive portfolio. UTMD's diverse product range serves various healthcare settings, including neonatal intensive care units, labor and delivery wards, women's health centers within hospitals, outpatient clinics, and physicians' offices. The company facilitates distribution through a combination of direct customer service and sales teams, independent consultants, and manufacturer representatives. Established in 1978, Utah Medical Products, Inc. maintains its headquarters in Midvale, Utah.
- Industry
- Medical - Instruments & Supplies
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Kevin L. Cornwell
- Listed since
- Mar 8, 1999
- Employees
- 146
Market position
Day range
Current $71.55
52-week range
Current $71.55
- Open
- $70.55
- Previous close
- $71.42
- Volume
- 114.14K
- 5.58× average
- Average volume
- 20.45K
- Average daily volume
- Market cap
- 227.82M USD
- Beta
- 0.36
- Market reference 1
- 50-day average
- $69.803
- +2.50% above average
- 200-day average
- $64.0965
- +11.63% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 95.78M USD
- P/E (TTM)
- 21.81×
- P/B (TTM)
- 1.87×
- P/S (TTM)
- 6.31×
- EV / EBITDA
- 5.61×
- Earnings yield
- 6.22%
- Free cash flow yield
- 7.90%
- Dividend yield
- 1.73%
Profitability & efficiency
- Gross margin
- 54.88%
- Operating margin
- 28.46%
- Net margin
- 29.04%
- Return on equity
- 9.46%
- Return on assets
- 9.21%
- Return on invested capital
- 7.60%
Financial health
- Debt / equity
- 0×
- Current ratio
- 37.62×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 38.52M USD | 40.9M USD | 50.22M USD | 52.28M USD | 49.05M USD |
| Cost of goods sold | 18.65M USD | 16.76M USD | 20.19M USD | 20.09M USD | 18.14M USD |
| Gross profit | 19.88M USD | 24.14M USD | 30.04M USD | 32.2M USD | 30.92M USD |
| Research and development | 668K USD | 813K USD | 560K USD | 493K USD | 526K USD |
| Selling, general, and administrative | 7.81M USD | 5.57M USD | 12.7M USD | 11.91M USD | 11.51M USD |
| Operating expenses | 8.47M USD | 10.55M USD | 13.26M USD | 12.41M USD | 12.04M USD |
| Interest income | — | 3.37M USD | — | 661K USD | 166K USD |
| Depreciation and amortization | 2.95M USD | 2.77M USD | 6.37M USD | 7.08M USD | 7.28M USD |
| Operating income | 11.4M USD | 13.59M USD | 16.78M USD | 19.79M USD | 18.88M USD |
| Net income | 11.29M USD | 13.87M USD | 16.64M USD | 16.47M USD | 14.79M USD |
Company facts updated Aug 24, 2026.
UTMD peers
ETFs holding UTMD
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI6.9M0.00%2.3T USD0.03%$378.24+0.44%
iShares Russell 2000 ETFIWM4.74M0.01%81.62B USD0.19%$299.96+0.77%
Fidelity Small-Mid Multifactor ETFFSMD2.81M0.09%2.5B USD0.15%$52.03+0.44%
Vanguard Extended Market ETFVXF2.35M0.00%93.7B USD0.05%$245.53+0.82%
U.S. Micro Cap Portfolio ETFDFMC2.16M0.03%8.06B USD0.43%$60.95+0.73%
iShares Russell 2000 Value ETFIWN2.02M0.01%14.66B USD0.24%$224.81+0.45%
Dimensional - US Targeted Value ETFDFAT1.37M0.01%14.66B USD0.28%$71.67+0.67%
Vanguard Russell 2000 ETFVTWO1.2M0.01%17.4B USD0.06%$121.25+0.74%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 6.9M
- Weight
- 0.00%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
iShares Russell 2000 ETFIWM- Market value
- 4.74M
- Weight
- 0.01%
- AUM
- 81.62B USD
- Expense ratio
- 0.19%
- Price / 1D
- $299.96+0.77%
Fidelity Small-Mid Multifactor ETFFSMD- Market value
- 2.81M
- Weight
- 0.09%
- AUM
- 2.5B USD
- Expense ratio
- 0.15%
- Price / 1D
- $52.03+0.44%
Vanguard Extended Market ETFVXF- Market value
- 2.35M
- Weight
- 0.00%
- AUM
- 93.7B USD
- Expense ratio
- 0.05%
- Price / 1D
- $245.53+0.82%
U.S. Micro Cap Portfolio ETFDFMC- Market value
- 2.16M
- Weight
- 0.03%
- AUM
- 8.06B USD
- Expense ratio
- 0.43%
- Price / 1D
- $60.95+0.73%
iShares Russell 2000 Value ETFIWN- Market value
- 2.02M
- Weight
- 0.01%
- AUM
- 14.66B USD
- Expense ratio
- 0.24%
- Price / 1D
- $224.81+0.45%
Dimensional - US Targeted Value ETFDFAT- Market value
- 1.37M
- Weight
- 0.01%
- AUM
- 14.66B USD
- Expense ratio
- 0.28%
- Price / 1D
- $71.67+0.67%
Vanguard Russell 2000 ETFVTWO- Market value
- 1.2M
- Weight
- 0.01%
- AUM
- 17.4B USD
- Expense ratio
- 0.06%
- Price / 1D
- $121.25+0.74%
Continue in GoAI
Research UTMDresearch.disclaimer





